Oncogenic Y641 mutations in EZH2 prevent Jak2/β-TrCP-mediated degradation. (Q54381671)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469040%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Oncogenic Y641 mutations in EZH2 prevent Jak2/β-TrCP-mediated degradation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469040%20AND%20SRC:MED&resulttype=core&format=json

Anagh Anant Sahasrabuddhe

6 March 2020

author

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469040%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Megan S Lim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469040%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Kojo Elenitoba-Johnson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469040%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

X Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469040%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

F Chung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469040%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

T Velusamy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469040%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

27 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469040%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469040%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469040%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469040%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

445-454

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24469040%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2013.571

6 March 2020

exact match

0 references

cites work

Epigenetic factors in cancer development: polycomb group proteins

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Consequences of the depletion of zygotic and embryonic enhancer of zeste 2 during preimplantation mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Polycomb proteins in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Roles of the Polycomb group proteins in stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

The Polycomb complex PRC2 and its mark in life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Occupying Chromatin: Polycomb Mechanisms for Getting to Genomic Targets, Stopping Transcriptional Traffic, and Staying Put

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Polycomb group proteins set the stage for early lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

EZH2 mutations are frequent and represent an early event in follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Epigenetic therapy of hematological malignancies: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

βTrCP regulates BMI1 protein turnover via ubiquitination and degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

PRAJA1 is a ubiquitin ligase for the polycomb repressive complex 2 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Function and regulation of cullin-RING ubiquitin ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

DNA damage regulates UHRF1 stability via the SCF(β-TrCP) E3 ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

SCF(FBXO22) regulates histone H3 lysine 9 and 36 methylation levels by targeting histone demethylase KDM4A for ubiquitin-mediated proteasomal degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Bimodal degradation of MLL by SCFSkp2 and APCCdc20 assures cell cycle execution: a critical regulatory circuit lost in leukemogenic MLL fusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Global identification of modular cullin-RING ligase substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Ubiquitin ligases: cell-cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Polycomb group protein-mediated repression of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Molecular architecture of human polycomb repressive complex 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Deletion analysis of BMI1 oncoprotein identifies its negative regulatory domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Recurrent reciprocal RNA chimera involving YPEL5 and PPP1CB in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571

Mechanisms of polycomb gene silencing: knowns and unknowns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.571